BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2017 11:43:15 AM | Browse: 1170 | Download: 2408
 |
Received |
|
2017-02-07 18:46 |
|
Peer-Review Started |
|
2017-02-12 23:11 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-03-10 17:19 |
|
Revised |
|
2017-03-17 13:29 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-03-29 10:09 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-04-10 09:07 |
|
Articles in Press |
|
2017-04-10 09:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-26 09:54 |
|
Publish the Manuscript Online |
|
2017-06-14 11:43 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Case Report |
| Article Title |
Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Puneet Gandhi, Richa Khare, Nitin Garg and Sandeep K Sorte |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| M.P. Biotech Council, M.P. for financial assistance and BMHRC for infrastructural facilities |
249 |
|
| Corresponding Author |
Dr. Puneet Gandhi, Professor, Head, Department of Research, Bhopal Memorial Hospital and Research Centre, Raisen Bypass Road, Bhopal 462038,
India. puneetgandhi67@yahoo.com |
| Key Words |
Glioblastoma multiforme; Immunophenotypic signature; Progression free survival; Molecular markers; Human telomerase reverse transcriptase; Interleukin-6; Tissue inhibitor of metalloproteinases-1; YKL-40; High mobility group-A1 |
| Core Tip |
Delineating the immunophenotypic signature for glioblastoma with reference to disease progression is of clinical importance. This case report presents for the first time a panel of 6 systemic molecular markers in circulation namely; human telomerase reverse transcriptase, interleukin-6, neutrophil-lymphocyte ratio, tissue inhibitor of metalloproteinases-1, human chitinase-3-like-protein-1 and high mobility group-A1 representing the mechanistic of inflammation, proliferation and invasion of the tumor. Their expression is suggested to be linked to progression-free survival in glioblastoma-multiforme. |
| Publish Date |
2017-06-14 11:43 |
| Citation |
Gandhi P, Khare R, Garg N, Sorte S. Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival. World J Clin Cases 2017; 5(6): 247-253 |
| URL |
http://www.wjgnet.com/2307-8960/full/v5/i6/247.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v5.i6.247 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
